Research Calls I
-
Upgrades:
- Acadia Realty Trust (AKR) upgraded to Buy from Neutral at Compass Point; tgt $27
- Alcon (ALC) upgraded to Neutral from Sell at Redburn Atlantic
- American Intl (AIG) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $89
- Bank of Marin (BMRC) upgraded to Buy from Neutral at DA Davidson; tgt $24
- Brinker (EAT) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $90
- Canadian Nat'l Rail (CNI) upgraded to Outperform from Sector Perform at RBC Capital Mkts
- CVS Health (CVS) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $82
- EVgo Inc. (EVGO) upgraded to Buy from Neutral at UBS; tgt raised to $8.50
- Fortive (FTV) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $92
- Lending Club (LC) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $15
-
Downgrades:
- American Tower (AMT) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $230
- Azul S.A. (AZUL) downgraded to Neutral from Buy at Seaport Research Partners
- Cirrus Logic (CRUS) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $120
- First Advantage Corp. (FA) downgraded to Peer Perform from Outperform at Wolfe Research
- Hexcel (HXL) downgraded to Hold from Buy at Vertical Research; tgt $65
- Honeywell (HON) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $235
- Hubbell (HUBB) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $454
- Huntington Ingalls (HII) downgraded to Hold from Buy at Vertical Research; tgt $275
- Huntington Ingalls (HII) downgraded to Peer Perform from Outperform at Wolfe Research
-
Others:
- Align Tech (ALGN) initiated with a Hold at Needham
- Banc of California (BANC) initiated with a Neutral at Citigroup; tgt $15
- Birkenstock Holding Plc (BIRK) initiated with a Buy at BTIG Research; tgt $60
- Builders FirstSource (BLDR) initiated with a Buy at Goldman; tgt $225
- Cabaletta Bio (CABA) initiated with a Buy at UBS; tgt $10
- Carrier Global (CARR) resumed with a Neutral from Underweight at JP Morgan; tgt raised to $83
- IperionX (IPX) initiated with a Buy at B. Riley Securities; tgt $30
- Kyverna Therapeutics (KYTX) initiated with a Buy at UBS; tgt $13